Tetravalent Influenza Vaccine approved by FDA in the United States
Recently, the US Food and Drug Administration (FDA) has approved an application for a supplementary biological product license from Sanofi’s Fluzone® High-Dose Quadrivalent (High dose tetravalent, Influenza Vaccine) for older people agedRead More…